Free Trial

XBiotech (XBIT) SEC Filings & 10K Form

XBiotech logo
$7.35
+0.09 (+1.24%)
(As of 11/1/2024 ET)

Recent XBiotech SEC Filings

DateFilerForm TypeView
08/12/2024
1:38 PM
XBiotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/21/2024
1:15 PM
Libby Peter (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
1:15 PM
MacAdam Donald H. (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
1:16 PM
Waldin Jan-Paul (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
1:16 PM
MCKENZIE W THORPE (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
11:57 AM
XBiotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
10:27 AM
XBiotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
3:46 PM
XBiotech (Filer)
Form DEFA14A
05/01/2024
3:49 PM
XBiotech (Filer)
Form ARS
05/01/2024
3:44 PM
XBiotech (Filer)
Form DEF 14A
05/01/2024
2:32 PM
XBiotech (Filer)
Form 10-K/A
03/15/2024
2:31 PM
XBiotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/07/2024
11:36 AM
SIMARD JOHN (Filed by)
XBiotech (Subject)
XBiotech (Subject)
Form SC 13G/A
02/07/2024
11:01 AM
MCKENZIE W THORPE (Filed by)
XBiotech (Subject)
Form SC 13G/A
02/07/2024
11:01 AM
GUT THOMAS (Filed by)
XBiotech (Subject)
Form SC 13G/A
01/05/2024
9:48 AM
SIMARD JOHN (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:00 AM
XBiotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
1:41 PM
XBiotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:XBIT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners